QualityStocks Stock Newsletters Archives - Page 783 of 1818

MondayMar 09, 2009 11:21 am

American Oriental Bioengineering, Inc (AOB) is Thriving in Today’s Sluggish World Economy

American Oriental Bioengineering, Inc, (NYSE:AOB) announced today that its fourth quarter 2008 revenues were up a whopping 68% to $96.3 million. Net income for the same period was up 43% to $21.7 million. The good news reflects the continued demand for the company’s pharmaceutical and nutritional products in the Chinese marketplace. American Oriental, based in China, is engaged in the development and production of plant based products, both pharmaceutical and nutritional. The products are produced from the leaves and roots of various plants. In the case of PBPs (Plant Based Pharmaceuticals), they are used to treat illnesses or associated symptoms…

MondayMar 09, 2009 10:26 am

SyntheMed, Inc. (SYMD.OB) Receives FDA Approval for REPEL-CV® Adhesion Barrier for Use in Pediatric Cardiac Surgery

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products. SyntheMed reached a major milestone when the company announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-Market Approval application for REPEL-CV® Adhesion Barrier for use in pediatric cardiac surgery patients. One of the unique aspects of REPEL-CV is that it is a bioresorbable film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the formation of post-operative adhesions (scar tissue). Robert P. Hickey, who serves as the President and CEO…

MondayMar 09, 2009 7:12 am

Cereplast, Inc. (CERP.OB) Contracted to Supply Bioplastics to Absorbent Specialty Products

Cereplast, Inc., a manufacturer of proprietary bio-based, sustainable plastics, announced that it will be supplying Absorbent Specialty Products with its bioplastic resin for the company’s new “Bio-Bones” Bone Replacement Prosthetics. “We’re very pleased that Absorbent Specialty Products selected our Compostables® resin for its Bio-bones product line,” said Frederic Scheer, Chairman and CEO of Cereplast. “It is encouraging to see more and more manufacturers developing and manufacturing products using sustainable alternatives to petroleum-based plastic products.” “We selected the Cereplast resin because of its natural ability to burn clean and turn to ash during cremation, as opposed to melting and emitting toxic…

MondayMar 09, 2009 7:06 am

Mymetics Corp. (MYMX.OB) Announces Acquisition of Virosome Biologicals B.V.

Mymetics Corporation announced shortly after the opening bell today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil Holding B.V., parent company of Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM). Virosome Biologicals B.V. is focused on developing a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines. As terms of the Share Purchase Agreement, Antonius Stegmann, co-founder and CSO of Virosome Biologicals B.V, will remain CSO of Virosome Biologicals B.V. The acquisition will expand Mymetics' current portfolio of vaccines, adding two collaborations: an Influenza vaccine in a Phase II Human Clinical…

MondayMar 09, 2009 4:36 am

KL Energy Corp. (KLEG.OB) Receives Multi-Million Dollar Capital Infusion despite Tough Economy

KL Energy Corp., a leading producer of second-generation cellulose-based ethanol (CBE), Friday announced it has secured $4 million of additional capital, which will fuel its efforts to hold its competitive position in the alternative energy market. Steve Corcoran, recently appointed CEO of KL Energy, said that even in such taxing economic times, the company’s operations and growth allowed it to attract investors who see the potential for its technology. "In spite of the current economic environment we were able to secure additional capital to continue our growth initiatives. This capital infusion is verification that KL Energy Corp. is positioned to…

MondayMar 09, 2009 4:28 am

Axial Vector Energy Corp. (AXVC.PK) Forms Joint Venture with Petrosonics, LLC

Yesterday, Axial Vector Energy announced that it has formed a Joint Venture with Petrosonics, LLC of Reno, Nevada. This new Joint Venture will be named Petro-AVEC. AVEC Acquisitions Corporation, a wholly owned subsidiary of Axial Vector, and Petrosonics have formed the Joint Venture to develop, finance and market Petrosonics' sulfur removal technology globally. Under the terms and conditions of the Joint Venture, AVEC Acquisitions will provide an initial $6.8 million of capital contributions. First, Petro-AVEC will concentrate its development, sales and marketing efforts in the worldwide refining industry. The Joint Venture will continue development of their proprietary technology for treatment…

FridayMar 06, 2009 7:44 am

Dr. Werner Lanthaler Appointed Chief Executive Officer of Evotec AG (EVTC)

Evotec AG announced that it has appointed Dr. Werner Lanthaler as its Chief Executive Officer, effective immediately. Previously, Dr. Lanthaler was Chief Financial Officer of Intercell AG in Vienna, Austria, a global biopharmaceutical leader focused on developing vaccines. In his position as CFO, he was also responsible for Business Development and Marketing & Sales. During his eight-year tenure at Intercell, the biopharmaceutical company evolved from a venture-backed biotechnology company into a global vaccine player. Dr. Lanthaler played a key role in many of the company's major corporate milestones including the most recent product approval of Intercell's Japanese Encephalitis Vaccine, the…

FridayMar 06, 2009 7:09 am

Pax Clean Energy, Inc. (PXCE.OB) Selects New Investor and Media Relations Firm

Pax Clean Energy, Inc. announced today that it has signed an agreement with Del Mar Corporate Communications, LLC (DMCC), based in California, to provide investor and media relations for the company. P.L. Hammond, C.A., President of Pax Clean Energy, commented, "We are very happy to have DMCC representing our company to broaden investor and industry awareness. Their expertise, focused method of implementing a long-term plan and history of success fits our company philosophy." Brian Hill, spokesman for DMCC, stated, "We are delighted to represent PXCE in its public affairs, and look forward to a long and successful relationship with their…

FridayMar 06, 2009 6:59 am

Genesis Pharmaceuticals Enterprises, Inc. (GNPH.OB) CFO Interviewed on Bloomberg TV Asia

Genesis Pharmaceuticals Enterprises, Inc., a U.S. pharmaceutical company with its principal operations in the People's Republic of China, announced that its CFO, Ms Elsa Sung, was featured in a live interview at the studios of Bloomberg TV Asia Pacific Channel. During the interview, she discussed recent health care reforms in China and Genesis' growth strategies. According to Ms Sung, the Chinese government intends to spend more than 850 billion Yuan on health care over the next three years. As part of health care reform, over 90% of China's population is expected to receive health care insurance coverage from the national…

FridayMar 06, 2009 6:50 am

Solutia Inc. (SOA) Re-affirms Guidance, Updates Investor Community

Solutia Inc. announced this morning that it is re-affirming its full-year 2009 adjusted EBITDA guidance from continuing operations of $325 million to $350 million and its full-year 2009 total cash from operations less capital expenditures guidance of $25 million to $75 million. The company based its decision to re-affirm the guidance on its performance through February. Jeffry N. Quinn, chairman, president and CEO of Solutia Inc., stated, "Overall, we are encouraged by the performance of our businesses so far in 2009. Revenue and adjusted EBITDA for the first two months met the company's expectations, with February results showing sequential improvement…

Site Search

Company Search

Category: QualityStocks Stock Newsletters